<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Genmab - Q&amp;A d. 11. maj 2020]]></title><description><![CDATA[<p dir="auto">Session med CEO, Prof. Jan Van de Winkel, Q1 Genmab</p>
<p dir="auto"><a href="https://nbg1.your-objectstorage.com/proinvestor-dev/forum/ir/cms/QA-Genmab%202020-05-11.pdf" rel="nofollow ugc">https://nbg1.your-objectstorage.com/proinvestor-dev/forum/ir/cms/QA-Genmab 2020-05-11.pdf</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/441355/genmab-qa-d-11-maj-2020</link><generator>RSS for Node</generator><lastBuildDate>Fri, 10 Jul 2026 18:35:56 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/441355.rss" rel="self" type="application/rss+xml"/><pubDate>Tue, 12 May 2020 04:59:49 GMT</pubDate><ttl>60</ttl><item><title><![CDATA[Reply to Genmab - Q&amp;A d. 11. maj 2020 on Wed, 13 May 2020 04:34:38 GMT]]></title><description><![CDATA[<p dir="auto">Tak Helge,<br />
Det er virkelig imponerende at du kan få Jan Van de Winkel i QA på Proinvestor og efterfølgende giver os der arbejder muligheden for at få samme information!</p>
]]></description><link>https://dev.proinvestor.com/forum/post/9459567</link><guid isPermaLink="true">https://dev.proinvestor.com/forum/post/9459567</guid><dc:creator><![CDATA[NyNovice]]></dc:creator><pubDate>Wed, 13 May 2020 04:34:38 GMT</pubDate></item></channel></rss>